The degradation of ornithine decarboxylase (ODC) catalyzed by the 26 S proteasome is accelerated by antizyme, an ODC inhibitory protein induced by polyamines. Previously, we have found another possible regulatory protein of ODC degradation, antizyme inhibitor. Antizyme inhibitor binds to the antizyme with a higher affinity than that of ODC, releasing ODC from ODCantizyme complex. We report here the cDNA sequence of rat heart antizyme inhibitor. The deduced sequence of the protein is highly similar to, but distinct from, sequences of ODCs from various species. Antizyme inhibitor contains amino acid residues required for formation of active sites of ODC, but it completely lacks ODC activity. Antizyme inhibitor has no homology with peptide sequence in the mammalian ODC carboxyl terminus, which is needed for rapid turnover of ODC. It inhibits antizyme-dependent ODC degradation, but, unlike ODC, its degradation is not accelerated by antizyme.Ornithine decarboxylase (ODC) 1 is a key enzyme in polyamine biosynthesis pathway (1, 2). The turnover of ODC is very rapid and highly regulated (3, 4). The degradation of ODC catalyzed by the 26 S proteasome is accelerated by ODC antizyme (5, 6), an inhibitory protein induced by polyamines (7). Strict regulation of ODC appears to be important for cell growth, because overproduction of ODC is associated with neoplastic transformation (8, 9), whereas overproduction of antizyme inhibits cell growth (10, 11). We previously found in rat liver and heart another possible regulator of ODC degradation, antizyme inhibitor (12). Antizyme inhibitor binds to the antizyme with a higher affinity than that of ODC and releases ODC from the ODC-antizyme complex (12)(13)(14). The physiological fluctuation of antizyme inhibitor in vivo suggested that it is another regulatory protein that stabilizes ODC by trapping antizyme (14). However, the possibility that antizyme inhibitor is a post-translationally modified product of ODC could not be ruled out. In this report, we describe the cloning and expression of antizyme inhibitor and show that the sequence of antizyme inhibitor is closely related to, but distinct from, that of ODC.
EXPERIMENTAL PROCEDUREScDNA Cloning-Oligo(dT)-primed cDNA was synthesized from poly(A) ϩ RNA from the hearts of isoproterenol-treated Wistar rats (10 mg/kg, 2 h) and inserted into ZAPII vector (Stratagene) through EcoRI adaptors to construct a library. One positive clone was selected from 10 5 recombinants by screening with a monoclonal antibody to rat heart antizyme inhibitor (14) as a probe. This monoclonal antibody does not react with rat ODC (14). The selected clone, A1, which carried a cDNA insert of about 1.9 kb in length was purified and sequenced. Two more positive clones were selected by plaque hybridization with a probe of the partial length cDNA A1. These clones, A2 and A3, carried cDNA inserts of about 2.2 and 4 kb, respectively, and were sequenced. All the DNA sequences were determined from both strands.Northern Blot Analysis of Antizyme Inhibitor mRNA-Poly(A) ϩ ...